TORONTO, Jan. 11 /CNW/ - Theralase(TM) Technologies Inc. (TSX-V: TLT &
OTC BB: TLTFF) ("Theralase"), a designer, manufacturer and distributor of
therapeutic medical laser systems, announced today that, effective
December 21, 2007, its Board of Directors appointed PricewaterhouseCoopers
LLP, Chartered Accountants ("Pricewaterhouse") as the Company's new
independent auditors, replacing the firm of Collins Barrow, Chartered
Accountants ("Collins Barrow").
